Cushing’s disease is treated primarily with surgery to remove the pituitary tumor causing excess cortisol production. When surgery doesn’t fully resolve the problem, medications, radiation, or removal of the adrenal glands can bring cortisol levels under control. The right approach depends on the size and location of the tumor, how your body responds to the first treatment, and whether the disease comes back.
Surgery Is the First-Line Treatment
The standard operation is called transsphenoidal surgery, where a surgeon reaches the pituitary gland through the nasal passages and sinuses rather than opening the skull. The goal is to remove the small, hormone-producing tumor (called an adenoma) while preserving the rest of the pituitary gland. It’s typically performed by a neurosurgeon with specific experience in pituitary tumors, and most patients spend only a few days in the hospital.
Overall remission rates hover around 64%, based on long-term data from specialized centers. Interestingly, smaller tumors don’t always guarantee better outcomes. In one 20-year retrospective series, remission rates were about 59% for smaller tumors and 74% for larger ones, likely because bigger tumors are sometimes easier to locate and fully remove during the procedure.
Success is measured by a morning blood cortisol level taken within the first week after surgery. A reading below 5 micrograms per deciliter generally signals remission. Many patients actually want their cortisol to drop very low right after surgery, because that suggests the tumor was completely removed and the remaining healthy pituitary tissue is suppressed from years of excess cortisol.
What Recovery From Surgery Looks Like
After a successful operation, your body can’t produce enough cortisol on its own right away. The pituitary and adrenal glands need time to “wake up” after being suppressed, sometimes for years. You’ll be placed on replacement cortisol (hydrocortisone) starting the day of surgery, at higher doses initially, then gradually stepped down over the following days. By roughly the third day after surgery, most patients are on a steady oral dose taken with meals.
The tapering process continues for weeks to months under the guidance of an endocrinologist. During this period, you may feel fatigued, achy, or generally unwell. These symptoms reflect your body adjusting to normal cortisol levels after being flooded with excess cortisol, sometimes for years. It’s an uncomfortable phase, but it’s actually a sign that the surgery worked. Full recovery of natural cortisol production can take anywhere from several months to over a year, and some patients need replacement therapy for even longer.
Medications to Lower Cortisol
When surgery isn’t an option, doesn’t achieve full remission, or the disease recurs, medications can reduce cortisol levels. These drugs fall into a few categories based on where they act in the body.
Drugs That Block Cortisol Production
The most effective newer option is osilodrostat, which blocks enzymes in the adrenal glands that produce cortisol. In a real-world study of 37 patients in Spain, 89% achieved a complete response, meaning their cortisol levels dropped to normal. The median time to reach normal cortisol was just four weeks, with two-thirds of complete responders getting there within the first month. Older medications in this class, like ketoconazole and metyrapone, work through similar mechanisms and have been used for decades, though they tend to require more frequent blood monitoring.
Drugs That Target the Pituitary Tumor
Pasireotide is an injectable medication that works directly on the pituitary tumor, reducing its production of the hormone (ACTH) that drives cortisol overproduction. It can shrink the tumor in some cases. The main drawback is a high risk of elevated blood sugar, which may require treatment with diabetes medications. Blood sugar monitoring is essential for anyone on this drug, and it’s often reserved for patients who can’t tolerate other options.
These medications are typically used as a bridge, either while waiting for another treatment to take effect or as long-term management when surgery and radiation haven’t been sufficient.
Radiation for Persistent Disease
Stereotactic radiosurgery delivers a focused beam of radiation to the pituitary tumor in a single session or a small number of sessions. It’s not the first treatment most people receive, but it plays an important role when surgery leaves behind residual tumor tissue or when the disease comes back.
The main limitation is time. Radiation doesn’t work immediately. In a Mayo Clinic study, 72% of patients treated with radiosurgery alone reached biochemical remission, but the median time to get there was 14 months. During that waiting period, most patients need cortisol-lowering medications to manage their symptoms.
Radiation also carries a risk of damaging the healthy pituitary tissue surrounding the tumor. About 15% of patients develop a new pituitary hormone deficiency within two years, rising to 22% at five years. The most common deficit is thyroid hormone production (affecting 20% of those at risk), followed by problems with growth hormone, sex hormones, and cortisol production itself. A small number of patients, about 6%, develop complete pituitary failure requiring lifelong replacement of multiple hormones.
Bilateral Adrenalectomy as a Last Resort
Removing both adrenal glands is the most definitive way to stop cortisol overproduction when every other approach has failed. It eliminates the source of cortisol entirely and is considered when surgery hasn’t worked, medications are poorly tolerated or only partially effective, radiation hasn’t achieved control, or a patient is too sick from severe cortisol excess to wait for slower treatments to take effect.
The operation is now done laparoscopically, and it provides immediate biochemical control. The tradeoff is significant: without adrenal glands, you’ll need to take both cortisol and a mineralocorticoid (a hormone that regulates salt and fluid balance) for the rest of your life. Missing doses can be dangerous, and you’ll need to adjust your dose during illness, injury, or surgery. This is a lifelong commitment that requires close partnership with an endocrinologist.
The Risk of Nelson Syndrome
Once the adrenal glands are gone, the pituitary tumor no longer gets the feedback signal that cortisol normally provides. In some patients, this causes the tumor to grow aggressively and produce very high levels of ACTH. This condition is called Nelson syndrome, and it develops in roughly 15 to 25% of adults who undergo bilateral adrenalectomy, typically one to four years after the procedure. In children, the risk is higher, ranging from 25 to 66%.
The most noticeable sign is darkening of the skin, caused by the excess ACTH. The growing pituitary tumor can also press on nearby structures, causing headaches or vision problems. Diagnosis involves tracking ACTH levels over time and periodic MRI scans of the brain. Because of this risk, anyone who has had both adrenal glands removed needs ongoing monitoring of their pituitary gland for years afterward.
Choosing a Treatment Path
Most people with Cushing’s disease start with transsphenoidal surgery performed by an experienced pituitary surgeon. If cortisol levels remain elevated or the disease returns, the next step is usually a cortisol-lowering medication, radiation, or both. Bilateral adrenalectomy is reserved for cases where these approaches haven’t been enough.
Treatment decisions depend heavily on your specific situation. A young patient with a clearly visible tumor and otherwise good health will likely follow a different path than someone with a recurrence after prior surgery or someone dealing with severe complications from prolonged high cortisol. Cushing’s disease is rare enough that outcomes tend to be better at specialized pituitary centers where surgeons and endocrinologists handle these cases regularly.